Why has the US short-seller, Hindenburg Research, which stung such corporate empires as Gautam Adani’s, shut shop? ‘We shook some empires that we felt needed shaking’, says its founder Nathan Anderson ...
A new study combines AI and blood screening to detect stage 1A breast cancer with 90-100 per cent accuracy. The approach could save lives but there are hurdles to it being used in hospitals.